YBX1 and breast carcinoma: Similarly, 2,4-dihydroxy-5-pyrimidinyl imidothiocarbamate (DPI) also inhibits the nuclear translocation of YB-1, suppressing breast cancer cell proliferation and metastasis and increasing the efficacy of Adriamycin [197].